Can Cent's One-Scan Protocol Outdo India's Legacy Preventive Healthcare Players?
Cent, a Bengaluru-based D2C preventive healthcare platform, offers a holistic full-body diagnostic protocol centred on early detection of cardiac disease, cancer, neurological disorders, and metabolic conditions. The startup has raised seed funding and has three centres i…
Intelligence analysis by Llama
Cent's single protocol test covers more than 80% of the human body and customers cannot pick and choose what tests they want. The startup has shifted its focus from longevity to clinical prevention and has partnered with third-party laboratories for blood sample collection and testing.
Cent is a company that helps people stay healthy by checking their bodies for diseases before they happen. They use a special machine called an MRI to look at the whole body and check for over 300 different conditions. They also do other tests to make sure the heart is working properly and to check for other problems. This way, people can catch diseases early and get treatment before it's too late.
Analysis
A $60B Vote of Confidence
Cent's founders, Shashank ND, Anshul Khandelwal, and Arpit Garg, have a deep understanding of India's healthtech ecosystem. They are betting that living longer shouldn't be left to chance, genetics, or a late-stage diagnosis. Instead, it should begin with catching diseases before they have a chance to take hold.
Cent's flagship offering is built around a full-body MRI, which takes around 30 minutes, generates 3-4 GB of imaging data per person, and screens for more than 300 conditions across the body, including neurodegenerative and spinal issues. However, MRI doesn't cover cardiac assessment well. For this, Cent has included three more tests a part of its protocol— a CT scan of the heart to check for calcification in arteries (which leads to blockages and attacks), an ECG and echocardiogram for the heart's functional and rhythmic capability, a DEXA scan for metabolic issues, and also a mammogram for women.
The process begins with users booking an appointment through Cent's website, followed by an at-home blood sample collection. They then visit a clinic at a scheduled time to undergo the remaining diagnostic tests. While Cent employs its doctors in-house, it partners with third-party laboratories for blood sample collection and testing.
Cent's single protocol test covers more than 80% of the human body and customers cannot pick and choose what tests they want. The startup has shifted its focus from longevity to clinical prevention and has partnered with third-party laboratories for blood sample collection and testing.
Why Cursor?
Cent's approach to preventive healthcare has the potential to make a significant impact on public health in India, where most preventive health checkups are largely insufficient and have very limited coverage of the body. The startup has raised seed funding and has three centres in Bengaluru, Delhi-NCR, and Mumbai.
The Road Ahead
Cent's founders are confident that their approach to preventive healthcare will make a significant difference in the lives of Indians. They are working towards establishing a comprehensive dedicated preventive health infrastructure and are committed to making a positive impact on public health in India.
Key points
- Cent offers a holistic full-body diagnostic protocol centred on early detection of cardiac disease, cancer, neurological disorders, and metabolic conditions.
- The startup has raised seed funding and has three centres in Bengaluru, Delhi-NCR, and Mumbai.
- Cent's single protocol test covers more than 80% of the human body and customers cannot pick and choose what tests they want.
- The startup has shifted its focus from longevity to clinical prevention and has partnered with third-party laboratories for blood sample collection and testing.
If Cent's approach to preventive healthcare is successful, it could lead to a significant reduction in premature deaths in India. The startup's focus on clinical prevention and its use of advanced diagnostic technologies could make a real difference in the lives of Indians.
However, there are also potential risks associated with Cent's approach. For example, the high cost of the diagnostic tests could make them inaccessible to many people. Additionally, the startup's reliance on third-party laboratories for blood sample collection and testing could lead to delays and errors.
